FDA Drug Recalls

1,018 recalls, newest first

Apr 13, 2022 Class II · Moderate risk

Albuterol Sulfate Inhalation Aerosol HFA with Dose Indicator

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0254-1007-52 D-1023-2022

Apr 13, 2022 Class II · Moderate risk

Adrenalin (epinephrine injection, USP)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 42023-168-01 D-1022-2022

Apr 13, 2022 Class III · Low risk

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-0201-03 D-1021-2022

Apr 13, 2022 Class II · Moderate risk

Albuterol Sulfate Inhalation Solution 0.083%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-9501-25 D-1020-2022

Apr 13, 2022 Class II · Moderate risk

Albuterol Sulfate Inhalation Solution 0.083%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-9501-03 D-1019-2022

Apr 13, 2022 Class II · Moderate risk

Albuterol Sulfate Inhalation Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-0301-01 D-1018-2022

Apr 13, 2022 Class II · Moderate risk

GlucaGen (glucagon)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0597-0260-10 D-1017-2022

Apr 13, 2022 Class II · Moderate risk

Firmagon (degarelix for injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55566-8403-01 D-1016-2022

Apr 13, 2022 Class II · Moderate risk

Firmagon (degarelix for injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55566-8303-01 D-1015-2022

Apr 13, 2022 Class II · Moderate risk

Epinephrine Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-101-02 D-1014-2022

Apr 13, 2022 Class II · Moderate risk

Epinephrine Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-102-02 D-1013-2022

Apr 13, 2022 Class II · Moderate risk

EPI-Pen Jr

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-501-02 D-1012-2022

Apr 13, 2022 Class II · Moderate risk

Dihydroergotamine Mesylate

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0574-0850-10 D-1011-2022

Apr 13, 2022 Class II · Moderate risk

Epidural Tray

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1010-2022

Apr 13, 2022 Class II · Moderate risk

Ampicillin for Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-113-10 D-1009-2022

Apr 13, 2022 Class II · Moderate risk

Betadine 5%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0411-30 D-1008-2022

Apr 13, 2022 Class II · Moderate risk

Sumatriptan Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0173-01 D-1007-2022

Apr 13, 2022 Class II · Moderate risk

Arzol (Silver Nitrate Applicator)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 12870-0001-02 D-1006-2022

Apr 13, 2022 Class II · Moderate risk

Olanzapine single dose vial Lyophilized

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0308-01 D-1005-2022

Apr 13, 2022 Class II · Moderate risk

Lidocaine Patch

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 42858-0118-30 D-1004-2022

Apr 13, 2022 Class II · Moderate risk

Dexmedetomidine HCL Single Dose Vial 200 mcg per 2 mL

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0209-02 D-1003-2022

Apr 13, 2022 Class II · Moderate risk

Bupivacaine HCl Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0171-10 D-1002-2022

Apr 13, 2022 Class II · Moderate risk

Bupivacaine HCl Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0250-50 D-1001-2022

Apr 13, 2022 Class II · Moderate risk

Bupivacaine HCl Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0249-50 D-1000-2022

Apr 13, 2022 Class II · Moderate risk

Bupivacaine HCl Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0170-30 D-0999-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061